Progression and Remittance of Traumatic Stress-related Symptoms During and After Narrative Exposure Therapy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 85
- 试验地点
- 2
- 主要终点
- Change in the progression of PTSD symptoms (PCL-5)
研究概览
简要总结
Narrative Exposure Therapy (NET) has been proven to be effective in the treatment of Posttraumatic Stress Disorder (PTSD) and trauma-related depression in more than a dozen controlled clinical trials. Symptom reduction was greatest during long-term follow-ups after the completion of the therapy.
In the current study, we will investigate the progression of PTSD symptoms and emotional stress before, during and after therapy. After a semi-structured interview all participants will be asked to report in monthly telephone interviews their core symptoms. Structured interviews after 6 and 12 months are used to validate the outcome. A convenience sample of individuals with a PTSD will be offered participation in the study.
详细描述
Participants will be recruited through the Center of Excellence for Psychotraumatology, University of Konstanz, with focus on refugees. All of them (approx. 100) will receive a structured interview and a detailed diagnosis. The interview includes questions about sociodemography, traumatic events, PTSD and depression symptomatology. Individuals with a PTSD diagnosis (up to 30) will be offered a Narrative Exposure Therapy (NET).
Irrespective of treatment and diagnosis, respondents are asked to participate in monthly telephone interviews assessing trauma-related and emotional distress and changes in life. Interviews assessing PTSD, depression symptoms and emotional distress will be conducted 6 and 12 months after the initial interview.
In addition, participants receiving NET will rate their PTSD symptoms and functionality prior to each therapy session.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 12 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •For treatment group: PTSD diagnosis (DSM-IV or V)
- •For non-treatment group: none
排除标准
- •Acute psychosis
- •Cerebro-organic disease
- •Acute drug or alcohol intoxication
- •Already receiving another psychotherapy
- •Anti-epileptic drugs at baseline
研究组 & 干预措施
Narrative Exposure Therapy
Participants with a PTSD diagnosis
干预措施: Narrative Exposure Therapy (Behavioral)
no / standard treatment
Participants with a PTSD diagnosis / other mental health problems / no mental health problems
结局指标
主要结局
Change in the progression of PTSD symptoms (PCL-5)
时间窗: baseline, 3 and 6 months follow-up
PTSD symptoms are measured with the PTSD Checklist - 5 (PCL-5; Weathers, Litz, et al., 2013)
次要结局
- Change in the progression of emotional distress symptoms (RHS-15)(up to 1 year)
研究者
Prof. Dr. Thomas Elbert
Professor for Clinical Psychology and Behavioural Neuroscience
University of Konstanz
